Perioperative Evaluation of Cerebellar Tumors

Active, not recruitingOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

February 28, 2021

Primary Completion Date

May 16, 2025

Study Completion Date

May 17, 2027

Conditions
Cerebellar TumorsBrain Tumor
Interventions
OTHER

Impact of Cerebellar Functional Topography on Cognition and Motor Ataxia

"Participants in this study will undergo surgical resection of their cerebellar or brain tumor (as per standard of care), as well as clinical and radiographic assessment, including: neurological physical examination (including Karnofsky Performance Scale (KPS) if conducted per Standard of Care), and magnetic resonance imaging (MRI) with or without diffusion tensor imaging (DTI)/tractography, prior to, immediately after, at one-month, 6-month, and 1-year follow-up status post-surgical resection. These data will also be collected at 18-month (±60 days) and 24-month (±60 days) visits post-surgery, if regular office visits with the neurosurgeon are scheduled at these two time points.~Only at baseline, the following will be conducted: Brief Ataxia Rating Scale (BARS) assessment score, Cerebellar Cognitive Affective Scale (CCAS/Schmahmann syndrome) scale score, Montreal Cognitive Assessment (MoCA) assessment, and a quality of life (QoL) assessment using the SF-36 questionnaire."

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER

NCT04463979 - Perioperative Evaluation of Cerebellar Tumors | Biotech Hunter | Biotech Hunter